Booming Biotech Market in India

Ask a question about this product »

Summary

Thanks to a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector, the Indian biotech industry has stupendously grown over the past few years. During FY 2005-FY 2009, the industry witnessed an impressive CAGR of around 26.5% and generated total revenue of INR 121.4 Billion (US$ 2.4 Billion) in FY 2009. Moreover, the industry has been able to survive successfully amid the global financial turmoil. Government initiatives, like set up of more biotech parks and encouragement to public-private-partnerships, provided cushion to the biotech industry against tough economic conditions of recession.

According to our new research report Booming Biotech Market in India, the year-on-year growth of the biotech market is expected to accelerate in near future on the back of high demand for vaccines, CROs, biopesticides, biofertilizers, biodiesel and biotherapeutics in India as well as at the global level. In this regard, we have done an extensive research and analysis of the biotech market together with its segments.

Our research has found that the biopharma segment constitutes a major part of the total biotech market. It has experienced consistent rise in revenue and the trend is likely to continue in future as well. Talking about future outlook of the overall biotech market, it will remain buoyant despite the recent economic downturn. The baseline for optimistic future projection of the market is pouring of investments to promote research and support entrepreneurship in the emerging segments. Besides, cutting edge research in globally emerging segments (such as contract bio-manufacturing services, clinical development services, etc) and developing in-house capability to manufacture innovative biopharma products will also pave the way for the Indian biotech market over the forecast period (FY 2011- FY 2013).

Our report provides comprehensive information, rational analysis and reliable statistics of the biotech market in India. The report has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible aftereffects of recession on the industry while making the report.

Contents

• 1. Analyst View
• 2. What Makes India Biotech Capable?
  • 2.1 Human Resources
  • 2.2 Costs
  • 2.3 Infrastructure & Manufacturing Capabilities
  • 2.4 Biodiversity
  • 2.5 IPR Laws
• 3. Indian Biotechnology Industry
  • 3.1 Market Overview
  • 3.2 Exports & Domestic Consumption
  • 3.3 Market Segments
    • 3.3.1 Biopharmaceuticals
    • 3.3.2 Bioservices
    • 3.3.3 Bioagriculture
    • 3.3.4 Industrial Biotechnology
    • 3.3.5 Bioinformatics
  • 3.4 Biosupplier Industry
  • 3.5 Manpower
  • 3.6 Future Prospects
• 4. Biotech Funding
• 5. Indian Bioclusters
  • 5.1 Southern Region
  • 5.2 Western Region
  • 5.3 Northern Region
  • 5.4 Eastern Region
• 6. Government Initiatives
• 7. Emerging Sectors
  • 7.1 Biogenerics
  • 7.2 Stem Cell Research
  • 7.3 Clinical Trials & CRO's
• 8. Regulatory Environment: Impact & RNCOS Recommendations
  • 8.1 R&D Cost & Time
  • 8.2 Dependency on Exports
  • 8.3 Patent Issues
  • 8.4 Gap between the Industry & Academia
• 9. Key Players Analysis
  • 9.1 Serum Institute of India
  • 9.2 Novo Nordisk
  • 9.3 Novozymes South Asia
  • 9.4 Biocon
  • 9.5 Panacea Biotech
• List of Figures:
  • Figure 3-1: Global - Biotechnology Market (Billion US$), 2007-2009
  • Figure 3-2: Biotechnology Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-3: Biotechnology Market by Sector (%), FY 2009
  • Figure 3-4: Biotechnology Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-5: Biopharmaceuticals Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-6: Forecast for Biopharmaceuticals Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-7: Biopharmaceuticals Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-8: Biopharmaceuticals Market by Segment (%), FY 2010
  • Figure 3-9: Vaccine Market (Million US$), FY 2009 to FY 2013
  • Figure 3-10: Therapeutics Market (Billion INR), FY 2010 to FY 2013
  • Figure 3-11: Therapeutics Market by Segment (%), FY 2006
  • Figure 3-12: Pathology Lab Market (Billion INR), 2007-2012
  • Figure 3-13: Share of Top Companies in Biopharmaceuticals Market (FY 2009)
  • Figure 3-14: Bioservices Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-15: Forecast for Bioservices Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-16: Bioservices Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-17: Share of Top Companies in Bioservices Market (FY 2009)
  • Figure 3-18: Bioagriculture Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-19: Forecast for Bioagriculture Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-20: Bioagriculture Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-21: Share of Top Companies in Bioagriculture Market (FY 2009)
  • Figure 3-22: Industrial Biotechnology Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-23: Forecast for Industrial Biotechnology Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-24: Industrial Biotechnology Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-25: Share of Top Companies in Industrial Biotechnology Market (FY 2009)
  • Figure 3-26: Bioinformatics Market (Billion INR), FY 2005 to FY 2010
  • Figure 3-27: Forecast for Bioinformatics Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-28: Bioinformatics Market by Exports & Domestic Consumption (%), FY 2009
  • Figure 3-29: Biosupplier Industry (Billion INR), FY 2005 to FY 2010
  • Figure 3-30: Forecast for Biosupplier Industry (Billion INR), FY 2011 to FY 2013
  • Figure 3-31: Forecast for Biotechnology Market (Billion INR), FY 2011 to FY 2013
  • Figure 3-32: Forecast for Biotechnology Market by Sector (%), FY 2013
  • Figure 4-1: Investment in Biotechnology R&D & Infrastructure (Billion INR), FY 2003 to FY 2007
  • Figure 5-1: Share of Top Regions in Biotechnology Market (FY 2009)
  • Figure 5-2: Share of Top Cities in Biotechnology Market (FY 2009)
  • Figure 7-1: Number of Clinical Trials (2007-2009)
  • Figure 7-2: Forecast for Number of Clinical Trials (2010-2012)
  • Figure 7-3: Clinical Trials by Phase (%)
  • Figure 7-4: Clinical Trials by Therapy (%)
  • Figure 7-5: Clinical Research Market (Million US$), 2007-2009
  • Figure 7-6: Forecast for Clinical Research Market (Million US$), 2010-2012
  • Figure 7-7: Pharma Outsourcing Market (Billion US$), 2007-2009
  • Figure 7-8: Pharma Outsourcing Market by Segment (%), 2008
  • Figure 9-1: Share of Top Companies in Biotechnology Market (FY 2009)
• List of Tables:
  • Table 2-1: Pharmaceutical Personnel in comparison to Other Countries (Numbers), 2003
  • Table 3-1: Turnover of Leading Vaccine Companies (Million INR), FY 2009
  • Table 3-2: Growth Infectious Diseases Diagnostic Market (2004-2008)
  • Table 3-3: Growth in Hormones Diagnostic Market (2004-2008)
  • Table 3-4: Growth in Blood Grouping Reagents Diagnostic Market (2004-2008)
  • Table 3-5: Growth in Pregnancy Diagnostic Market (2004-2008)
  • Table 3-6: Growth in Cancer Markers Diagnostic Market (2004-2008)
  • Table 3-7: Top 5 Biopharmaceutical Companies by Revenue (Million US$), FY 2009
  • Table 3-8: Top 10 Biosupplier Companies by Revenue (Billion INR), FY 2008
  • Table 5-1: Biotechnology Market by Top Bioclusters (Billion INR), FY 2008 & FY 2009
  • Table 5-2: Leading Biotechnology Companies in Southern Region (Billion INR), FY 2009
  • Table 9-1: Top 10 Biotechnology Companies by Revenue (Billion INR), FY 2009
  • Table 9-2: Serum Institute of India - Strengths & Weaknesses
  • Table 9-3: Novo Nordisk - Strengths & Weaknesses
  • Table 9-4: Novozymes South Asia - Strengths & Weaknesses
  • Table 9-5: Biocon - Strengths & Weaknesses
  • Table 9-6: Panacea Biotech - Strengths & Weaknesses

Related products